Ligand validation:8BDM

QE9: (2~{S},4~{R})-~{N}-[[2-(2-methoxyethoxy)-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{R})-3-methyl-2-(3-methyl-1,2-oxazol-5-yl)butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide

QE9 is a Ligand Of Interest in 8BDM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BDM_QE9_L_301	71%	68%	0.128	0.951	0.71	0.51	1	-	0	0	100%	1
8BDM_QE9_C_301	60%	68%	0.144	0.931	0.71	0.51	1	-	0	0	100%	1
8BDM_QE9_F_301	57%	67%	0.144	0.919	0.69	0.56	1	-	0	0	100%	1
8BDM_QE9_I_301	50%	67%	0.15	0.9	0.71	0.54	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.